Litcius/Paper detail

Manganese-Based Nanoactivator Optimizes Cancer Immunotherapy <i>via</i> Enhancing Innate Immunity

Lin Hou, Chunyu Tian, Yingshan Yan, Lewen Zhang, Huijuan Zhang, Zhenzhong Zhang

2020ACS Nano309 citationsDOI

Abstract

to augment cGAS/STING activity. We found that PL/APMP-DOX NPs with superior tumor-targeting capacity boosted dendritic cell maturation and increased cytotoxic T lymphocyte infiltration as well as natural killer cell recruitment into the tumor site. Furthermore, the NPs increased production of type I IFN and secretion of pro-inflammatory cytokines (for example, TNF-α and IL-6). Consequently, PL/APMP-DOX NPs exhibited excellent antitumor efficacy and prolonged the lifespan of the tumor-bearing mice. Collectively, we developed a PL-decorated Mn-based hybrid nanoactivator to intensify immune activation and that might provide therapeutic potential for caner immunotherapy.

Topics & Concepts

Innate immune systemTumor microenvironmentStimulator of interferon genesImmune systemChemistryImmunotherapyInterferonCancer immunotherapyCancer researchImmunityBiologyImmunologyinterferon and immune responsesExtracellular vesicles in diseaseImmune cells in cancer
Manganese-Based Nanoactivator Optimizes Cancer Immunotherapy <i>via</i> Enhancing Innate Immunity | Litcius